An IL-2/Ig Fusion Protein Influences CD4+T Lymphocytes in Naive and Simian Immunodeficiency Virus-Infected Rhesus Monkeys-Reference-Cited by-同舟云学术

An IL-2/Ig Fusion Protein Influences CD4+T Lymphocytes in Naive and Simian Immunodeficiency Virus-Infected Rhesus Monkeys

Published:2001-07-15 Issue:10 Volume:17 Page:873-886
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Craiu Abie¹,Barouch Dan H.²,Zheng Xin Xiao³,Kuroda Marcelo J.²,Schmitz Joern E.²,Lifton Michelle A.²,Steenbeke Tavis D.²,Nickerson Christy E.²,Beaudry Kristin²,Frost Julie D.²,Reimann Keith A.²,Strom Terry B.³,Letvin Norman L.²

Affiliation:

1. Science Research Laboratory, Somerville, Massachusetts 02115

2. Division of Viral Pathogenesis, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.

3. Division of Immunology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922201750290005

Reference47 articles.

1. Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease

2. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

3. 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine

4. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

5. Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering IL-2 for immunotherapy of autoimmunity and cancer;Nature Reviews Immunology;2022-02-25

2. Interleukin 2-Based Fusion Proteins for the Treatment of Cancer;Journal of Immunology Research;2021-11-08

3. Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy;PLOS ONE;2017-07-05

4. Construction and Functional Characterization of a Fusion Protein Interleukin-21/Immunoglobulin for Long-Term In Vivo Biodisponibility;DNA and Cell Biology;2016-03

5. Novel IL-2-Poly(HPMA)Nanoconjugate Based Immunotherapy;Journal of Biomedical Nanotechnology;2015-09-01